Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Substance P antagonists described by Pfizer

March 14, 1997

Knoll claims two series of compounds for CNS disorders

March 14, 1997

Akzo Nobel reveals new dopamine antagonists

March 14, 1997

NMDA antagonists claimed by Novartis

March 14, 1997

Antiparkinson Rx from Sumitomo in pivotal European trials

March 13, 1997

Somatostatin receptor antagonists prepared by Novartis

March 13, 1997

First approval for naratriptan

March 12, 1997

Pfizer initiates clinical trial in panic disorder

March 12, 1997

Bayer claims potassium channel modulators

March 12, 1997

Cytogen seeks Canadian approval for Quadramet

March 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...